Selective review surveys AI innovations and strategies for advancing precision oncology using multi-omics data.
Integrating multi-omics data with Artificial Intelligence offers new opportunities for understanding cancer biology and discovering actionable biomarkers. In this selective review aimed at clinicians and translational researchers, we survey methodological innovations from classical machine learning to deep learning. We synthesize recent innovations, identify persistent technical challenges, and evaluate the landscape of available multi-omics datasets. Ultimately, we propose a strategic roadmap for translating AI-driven integrative models into real-world precision oncology.
No takes yet. Share an insight, caveat, or question.
Bochaton et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: